Study blood features and clot risk in sickle cell disease
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at differences in red blood cells and how likely they are to form clots in people with sickle cell disease. The goal is to better understand clot risk and what blood markers may predict it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have sickle cell disease
- You must be older than 18 years
- You cannot be pregnant during the study
- You should not be under protective guardianship or curatorship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood samples to learn more about sickle cell-related genetics and biology. You might benefit indirectly by helping researchers understand the condition, even though this is laboratory research rather than a medication trial.
This study looks at whether red blood cell exchange (a treatment that replaces some of your blood with donor blood) can help reduce inflammation and blood clotting problems in people with sickle cell disease. If you are already on this treatment, it may help doctors understand how it affects your body.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
This study measures how well blood flows through brain arteries in children with sickle cell disease using a noninvasive ultrasound test. It may help doctors better understand stroke risk and how treatments like hydroxyurea or recent care affect blood flow.
This study looks at how children with sickle cell disease experience and manage pain crises, known as vaso-occlusive crises. The goal is to better understand these events to improve care for children living with this condition.
This study collects blood and urine samples from adults to help researchers understand diseases affecting blood vessels. Your donation helps scientists develop better treatments.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.